Quantitative temporal viromics: an approach to investigate host-pathogen interaction MP Weekes, P Tomasec, EL Huttlin, CA Fielding, D Nusinow, RJ Stanton, ... Cell 157 (6), 1460-1472, 2014 | 476 | 2014 |
Modulation of natural killer cells by human cytomegalovirus GWG Wilkinson, P Tomasec, RJ Stanton, M Armstrong, V Prod’homme, ... Journal of clinical virology 41 (3), 206-212, 2008 | 310 | 2008 |
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication RJ Stanton, K Baluchova, DJ Dargan, C Cunningham, O Sheehy, ... The Journal of clinical investigation 120 (9), 2010 | 285 | 2010 |
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture DJ Dargan, E Douglas, C Cunningham, F Jamieson, RJ Stanton, ... Journal of General Virology 91 (6), 1535-1546, 2010 | 243 | 2010 |
Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection VB O’Donnell, D Thomas, R Stanton, JY Maillard, RC Murphy, SA Jones, ... Function 1 (1), zqaa002, 2020 | 199 | 2020 |
The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1− NK cells V Prod’homme, C Griffin, RJ Aicheler, ECY Wang, BP McSharry, ... The Journal of Immunology 178 (7), 4473-4481, 2007 | 197 | 2007 |
Human cytomegalovirus: taking the strain GWG Wilkinson, AJ Davison, P Tomasec, CA Fielding, R Aicheler, ... Medical microbiology and immunology 204, 273-284, 2015 | 173 | 2015 |
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation CA Fielding, R Aicheler, RJ Stanton, ECY Wang, S Han, S Seirafian, ... PLoS pathogens 10 (5), e1004058, 2014 | 153 | 2014 |
Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function RJ Stanton, BP McSharry, M Armstrong, P Tomasec, GWG Wilkinson Biotechniques 45 (6), 659-668, 2008 | 145 | 2008 |
A prenylated dsRNA sensor protects against severe COVID-19 A Wickenhagen, E Sugrue, S Lytras, S Kuchi, M Noerenberg, ML Turnbull, ... Science 374 (6567), eabj3624, 2021 | 141 | 2021 |
Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A … BP McSharry, HG Burgert, DP Owen, RJ Stanton, V Prod'homme, ... Journal of virology 82 (9), 4585-4594, 2008 | 141 | 2008 |
Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112 V Prod'homme, DM Sugrue, RJ Stanton, A Nomoto, J Davies, ... Journal of General Virology 91 (8), 2034-2039, 2010 | 138 | 2010 |
Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18 V Prod’homme, P Tomasec, C Cunningham, MK Lemberg, RJ Stanton, ... The Journal of Immunology 188 (6), 2794-2804, 2012 | 127 | 2012 |
Impact of sequence variation in the UL128 locus on production of human cytomegalovirus in fibroblast and epithelial cells I Murrell, P Tomasec, GS Wilkie, DJ Dargan, AJ Davison, RJ Stanton Journal of virology 87 (19), 10489-10500, 2013 | 110 | 2013 |
Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses W Smith, P Tomasec, R Aicheler, A Loewendorf, I Nemčovičová, ... Cell host & microbe 13 (3), 324-335, 2013 | 109 | 2013 |
High-definition analysis of host protein stability during human cytomegalovirus infection reveals antiviral factors and viral evasion mechanisms K Nightingale, KM Lin, BJ Ravenhill, C Davies, L Nobre, CA Fielding, ... Cell host & microbe 24 (3), 447-460. e11, 2018 | 108 | 2018 |
The pentameric complex drives immunologically covert cell–cell transmission of wild-type human cytomegalovirus I Murrell, C Bedford, K Ladell, KL Miners, DA Price, P Tomasec, ... Proceedings of the National Academy of Sciences 114 (23), 6104-6109, 2017 | 103 | 2017 |
Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141 JL Hsu, DJH van den Boomen, P Tomasec, MP Weekes, R Antrobus, ... PLoS pathogens 11 (4), e1004811, 2015 | 100 | 2015 |
Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients R Stanton, D Westmoreland, JD Fox, AJ Davison, GWG Wilkinson Journal of medical virology 75 (1), 42-46, 2005 | 94 | 2005 |
Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation CA Fielding, MP Weekes, LV Nobre, E Ruckova, GS Wilkie, JA Paulo, ... Elife 6, e22206, 2017 | 93 | 2017 |